Larvol Delta - A-Phase-II-Study-of-Axicabtagene-Ciloleucel-an-AntiCD19-Chimeric-Antigen-Receptor-CAR-Tcell-Therapy-in-Combination-With-Radiotherapy-RT-in-RelapsedRefractory-Follicular-Lymphoma

cyclophosphamide - Generic mfg.

Yescarta (axicabtagene ciloleucel) - Gilead

http://clinicaltrials.gov/ct2/show/NCT06043323

Sep 5, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next